Resultados de la búsqueda 291-300 de 2994 para anti-TNF drugs
The purpose of this study is to to determine the individual treatment effect of somatostatin and whether duration of antibiotic therapy coupled with octreotide ...
The purpose of this study is to evaluate the effectiveness and safety of durvalumab versus placebo following Stereotactic Body Radiation Therapy (SBRT) in ...
... anti-PD-[L]-1 therapy. Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia. Rochester, Minn. This phase I trial ...
Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them ...
The study will enroll advanced cancer patients with unresectable or metastatic disease who are refractory to or are not candidates for standard approved therapy ...
2021; doi:10.1111/bjd.20080. FDA drug safety communication: FDA warns of rare but serious hypersensitivity reactions with certain over-the-counter topical acne ...
Mayo Clinic Minute: Dermatologist explains light therapy for skin April 11, 2024, 04:00 p.m. CDT · Mayo Clinic Minute: How often should you wash your hair ...
FDA Drug Safety Communication: FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes.
Perfusion MRI for Therapy Response Assessment in Brain Cancer. Scottsdale/Phoenix, Ariz. The purpose of this study is to improve patient care by optimizing and ...
... Therapy Treatment for a Brain Tumor. Rochester, Minn. This phase III trial compares memantine to usual treatment in treating patients with brain tumors that ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?